Suraksha Diagnostic IPO Sales, Profits, and other Financial Details - What you should know about the Suraksha Diagnostic IPO

Suraksha Diagnostic IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

IPO Details IPO GMP IPO Subscription Reviews About Company IPO Timeline KPI Financial Information Peer Comparison Allotment

Financial Information of Suraksha Diagnostic Limited IPO
The Revenues from operations for the Three Months of September 30, 2024, Fiscals 2024, 2023 and 2022 were ₹618.49 Million, ₹2,222.60 Million, ₹1,936.87 Million and ₹2,257.68 Million, respectively. The EBITDA for the Three Months of September 30, 2024, Fiscals 2024, 2023 and 2022 were ₹217.21 Million, ₹728.39 Million, ₹474.79 Million and ₹652.53 Million, respectively. The Profit after Tax for the Three Months of September 30, 2024, Fiscals 2024, 2023 and 2022 was ₹76.67 Million, ₹231.27 Million, ₹60.65 Million and ₹208.24 Million, respectively.

Suraksha Diagnostic Limited Financial Information (Restated Consolidated)

Amount in (₹ in Million)

Period Ended	June 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Reserve of Surplus	1,767.96	1,708.79	1,473.97	1,373.13
Total Assets	3,141.99	3,002.07	2,811.95	2,759.59
Total Borrowings	1,275.82	1,210.60	1,257.34	1,301.31
Fixed Assets	1,365.33	1,350.50	1,127.89	1,175.54
Cash	44.21	25.20	21.62	31.89
Net Borrowing	1,231.61	1,185.40	1,235.72	1,269.42
Revenue	618.49	2,222.60	1,936.87	2,257.68
EBITDA	217.21	728.39	474.79	652.53
PAT	76.67	231.27	60.65	208.24
EPS	1.49	4.43	1.22	3.91

Note 1:- RoE & ROCE calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit for the Year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price after Issue, given in Financial Express.